Back to Authors

Rosen, Galit

Mayo Clinic

Syndax Pharmaceuticals (United States)

Citations 2

P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIONATE USE PROGRAM EXPERIENCE
Stein, Eytan M. , Shukla, Neerav , Khera, Nandita , Rosen, Galit, Ghiraldi, Rachel, Nguyen, Huy Van, McNeer, Nicole, Zwaan, C. Michel , Rubnitz, Jeffrey E. , Issa, Ghayas , Stock, Wendy , Žučenka, Andrius , Khazal, Sajad Jawad , Stieglitz, Elliot , Rubinstein, Jeremy , Nguyen, Huy Van

HemaSphere | August 22, 2023 | Volume: 7 | Issue: S3 | Pages: e221187f

10.1097/01.hs9.0000969148.22118.7f Get It

Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience
Issa, Ghayas C., Cuglievan, Branko , Stein, Eytan M. , Arellano, Martha , Khera, Nandita , Stone, Richard M. , Thirman, Michael J. , Karras, Nicole, Gu, Yu , Bagley, Rebecca G., Rosen, Galit, Tamang, David, Dishman, Kimberly, Scalera, Sushama, Meyers, Michael L., Madigan, Kate, McNeer, Nicole, Issa, Ghayas , Žučenka, Andrius , DiPersio, John F. , Madigan, Kate, Aldoss, Ibrahim

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 914-916

10.1182/blood-2022-164600 Get It